GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » PanGenomic Health Inc (XCNQ:NARA) » Definitions » EV-to-EBITDA

PanGenomic Health (XCNQ:NARA) EV-to-EBITDA : -0.12 (As of Jun. 06, 2024)


View and export this data going back to 2022. Start your Free Trial

What is PanGenomic Health EV-to-EBITDA?

EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, PanGenomic Health's enterprise value is C$1.45 Mil. PanGenomic Health's EBITDA for the trailing twelve months (TTM) ended in Sep. 2023 was C$-11.75 Mil. Therefore, PanGenomic Health's EV-to-EBITDA for today is -0.12.

The historical rank and industry rank for PanGenomic Health's EV-to-EBITDA or its related term are showing as below:

XCNQ:NARA' s EV-to-EBITDA Range Over the Past 10 Years
Min: -19.07   Med: 0   Max: 0
Current: -0.12

XCNQ:NARA's EV-to-EBITDA is ranked worse than
100% of 462 companies
in the Healthcare Providers & Services industry
Industry Median: 12.675 vs XCNQ:NARA: -0.12

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2024-06-06), PanGenomic Health's stock price is C$0.08. PanGenomic Health's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Sep. 2023 was C$-1.232. Therefore, PanGenomic Health's PE Ratio for today is At Loss.

The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio.


PanGenomic Health EV-to-EBITDA Historical Data

The historical data trend for PanGenomic Health's EV-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

PanGenomic Health EV-to-EBITDA Chart

PanGenomic Health Annual Data
Trend Dec21 Dec22
EV-to-EBITDA
- -2.13

PanGenomic Health Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23
EV-to-EBITDA Get a 7-Day Free Trial Premium Member Only Premium Member Only -2.85 -2.13 -0.74 -0.40 -0.39

Competitive Comparison of PanGenomic Health's EV-to-EBITDA

For the Health Information Services subindustry, PanGenomic Health's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


PanGenomic Health's EV-to-EBITDA Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, PanGenomic Health's EV-to-EBITDA distribution charts can be found below:

* The bar in red indicates where PanGenomic Health's EV-to-EBITDA falls into.



PanGenomic Health EV-to-EBITDA Calculation

PanGenomic Health's EV-to-EBITDA for today is calculated as:

EV-to-EBITDA=Enterprise Value (Today)/EBITDA (TTM)
=1.454/-11.747
=-0.12

PanGenomic Health's current Enterprise Value is C$1.45 Mil.
PanGenomic Health's EBITDA for the trailing twelve months (TTM) ended in Sep. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was C$-11.75 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


PanGenomic Health  (XCNQ:NARA) EV-to-EBITDA Explanation

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

PanGenomic Health's PE Ratio for today is calculated as:

PE Ratio=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=0.08/-1.232
=At Loss

PanGenomic Health's share price for today is C$0.08.
PanGenomic Health's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Sep. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was C$-1.232.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio.

Please read Which price ratio outperforms the enterprise multiple?


PanGenomic Health EV-to-EBITDA Related Terms

Thank you for viewing the detailed overview of PanGenomic Health's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


PanGenomic Health (XCNQ:NARA) Business Description

Traded in Other Exchanges
Address
3800 Wesbrook Mall, Suite 102, Vancouver, BC, CAN, V6S 2L9
PanGenomic Health Inc is a precision health company that has developed a self-care digital platform to deliver personalized, evidence-based information about natural treatments to support mental health. The company's mobile app, the Nara App, provides consumers with a knowledge base tailored to an individual's user profile, developed by tracking a user's treatment regimen and their specific genomic, proteomics, and microbiome data. The Company's mission is to promote and improve the health and wellness of people and society by providing a technology platform that identifies plant-based solutions tailored to the health profile of each individual.
Executives
Kaidong Zhang Senior Officer

PanGenomic Health (XCNQ:NARA) Headlines

No Headlines